MAIA MAIA
Company Profile ↓Company Overview
MAIA (MAIA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -11.39% |
| 6 Months: | -30.00% |
| 3 Months: | +0.72% |
| 1 Month: | -4.76% |
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)56.97 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 52.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | - | -2.23M | -3.44M | -3.44M | -5.10M | -4.18M | -4.66M | -4.96M | -3.95M | -3.82M | -4.19M | -5.43M | -5.17M | -9.36M | -6.95M |
| Net Income | -3.43M | - | - | -3.31M | - | - | - | - | -8.07M | -8.88M | -2.74M | -4.52M | -5.35M | -8.90M | -6.37M |
| Diluted EPS | -0.78 | -1.02 | -0.50 | -0.40 | -0.48 | -0.38 | -0.35 | -0.36 | -0.46 | -0.40 | -0.11 | -0.16 | -0.18 | -0.27 | -0.14 |
| R&D Expense | 643.99K | 1.08M | 2.08M | 2.12M | 2.34M | 2.20M | 2.60M | 2.60M | 2.32M | 2.05M | 2.67M | 3.20M | - | - | 43.65K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | - |
| Operating Income | -7.79M | -16.18M | -20.18M | -16.96M | -24.27M |
| Net Income | -12.50M | -16.22M | -19.77M | -23.25M | -22.40M |
| Diluted EPS | -2.37 | -1.75 | -1.49 | -1.05 | -0.70 |
| R&D Expense | 3.50M | 8.93M | 11.11M | 10.01M | 453.75K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 11.33M | 12.02M | 7.57M | 10.16M | 9.70M |
| Total Equity | -1.62M | 9.18M | 8.51M | 477.51K | 3.63M | 2.38M |
| Cash & Equivalents | - | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | - | 2.15M | 3.51M | 7.09M | 6.52M | 7.33M |
| Current Liabilities | - | 2.15M | 3.27M | 4.94M | 3.83M | 5.84M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -4.12M | -12.10M | -13.07M | -15.70M | -18.84M |
| Financing Cash Flow | 14.03M | 12.48M | 9.27M | 18.18M | 17.91M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | -136.2% | -190.6% | -4,140.8% | -639.8% | -942.7% |
| ROCE % | -84.8% | -184.8% | -767.5% | -268.1% | -627.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MAIA
MAIA Biotechnology Executives Increase Stock Holdings, Express Confidence in Cancer Immunotherapy Development - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxQeW1fdVE1YzY1NkNTLWQtb2hiUHdZSVR5dXY5ZEp6SlRGNGxnc1d2YVNKMDJRd2lRQ1VNMVlRTTlJZllXQ211NDZsNDZLWDhjMGpBMnFXcldDMVVtS3dtbkNQVTdrOThGRVJFVDVCWTNFX1JqZW1uNW1YTEZSUVZaVFlnUl9uOEhRUHF6az…
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOTXpwbUtpTFdaRWlDOXQ0UEJETEdJTXZEVU1saV84cWppZmlQMThULUN0VEhBMEVrOEFoUFNyNVBEWjB3OUhWYVBDcWU3SXB1bHJFWU9tSFl0ZkVWTlZpRkZTbmFqQVlkUW5Uc3NUMFRzT3RiQlNWY3JFVE51TlNfQ0RaTWNfT1BBUmE1bl…
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMivgJBVV95cUxQaEw4UV9nblo5WEtJanI1TGJEUUtsTlFHSUo2YkR2SEUwSEVfS0M3VFZRanc1YUdwUTFxTDJ1YlE2X0hIUXF1WEU4ZUtZcHRUdHFRY1dObU9OOE83Z2x3Umxmby1XOC1GLW1WUjVNdUFEXzJxY0R6Z2MzMEZpclkxdXBtQWRaNTZRUEFaSm…
MAIA Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9pVDl4dE10S3B6STdoSk9GeldJQXp3NGtNa1pqVHgtQnIzT2p3R3pRTGt0amdPZllwMmVtQ21YRzZGMksyUlRCcUl0bU8yR3RxUkY1cUJGbVR3NTFER1hrOTdIM1lZNkhYVngxSXRLVnJJWEY1NHN3?oc=5" target="_blank">MAIA Fo…
MAIA finishes THIO-101 enrollment abroad, with 41 lung cancer patients treated - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNY0xSYzBLb0VPd3NWeHVpTkdJZEg1Wl9rUFpLMTc0ak12TjVOemlHTWNhTkgySnY4SEFnVm1DcUFzRllVSkRWS3NhQTR6empHZXpWX0NaOHhrR1dJckNhMm90QU85Y0x3QnhYQlF6ZS11SWcwb1ZLOUNsWHp0ZUlFaDFaUXdXWGRUbTQ5ZH…
MAIA Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTFBvV25aSGxOdmh5Qy1tcHp1T1RmTHZjZ3NZeDh2cUtWN3JpSWMwZF9naWVSR2RlenRVbXgwODZTT1pSM3F5cFA2S3dQMWtQRVZocG5TX2h2Yk9MN2swT2c?oc=5" target="_blank">MAIA Should I Buy</a> <font c…
MAIA — Frequently Asked Questions
What is the current share price of MAIA?
As of 2026-08-05 17:25 PDT, MAIA trades at $1.40 on NASDAQ/NYSE. Its 52-week range is $0.87 to $2.95.
What is the P/E ratio of MAIA?
MAIA trades at a trailing price-to-earnings (P/E) ratio of -2.00.
Is MAIA a good stock to buy?
This page provides a data-driven analysis of MAIA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.